MICHELE BRANNAN: Open Payments
NPI 1083621452 · ALTON, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$300 in 13 payments from 9 companies in 2025. Trend: 2023 $804 · 2024 $1,187 · 2025 $300
Food & beverage: $223Education: $77
| Company | Payments | Amount |
|---|---|---|
| Lundbeck LLC | 2 | $77 |
| Astellas Pharma US Inc | 2 | $49 |
| Lilly USA, LLC | 2 | $46 |
| AstraZeneca Pharmaceuticals LP | 2 | $34 |
| GlaxoSmithKline, LLC. | 1 | $23 |
| ABBVIE INC. | 1 | $20 |
| Novo Nordisk Inc | 1 | $20 |
| Kowa Pharmaceuticals America, Inc. | 1 | $16 |
| PFIZER INC. | 1 | $14 |
Products named: REXULTI, Veozah, MOUNJARO, AIRSUPRA, TRELEGY ELLIPTA, VRAYLAR, Ozempic, ZORYVE.
Industry payments across IL — which companies pay providers there.
